藻類來源的二十二碳六烯酸 (DHA) 市場 - 2026-2031 年預測

預計藻類衍生的二十二碳六烯酸 (DHA) 市場將保持 6.9% 的複合年成長率，從 2025 年的 14.38 億美元成長到 2031 年的 21.46 億美元。

藻類來源的二十二碳六烯酸 (DHA) 是一種對大腦發育和功能至關重要的必需Omega-3脂肪酸，作為一種永續的素食替代品，正日益受到關注，以取代傳統的魚類來源。藻類來源的DHA由微藻類生產，不僅解決了過度捕撈和環境影響的問題，也滿足了純素和素食者的需求——由於人體自身合成DHA的能力有限，他們需要從外部攝入DHA。更廣泛的DHA市場涵蓋了醫藥、食品飲料以及其他眾多領域的應用，並以油、粉末和軟膠囊等形式面向個人消費者和工業終端用戶。

市場成長主要受營養保健品和製藥業的擴張等因素驅動。隨著對高品質營養保健品的需求不斷成長，藻類來源的DHA已成為關鍵成分，尤其是在亞太和非洲等快速成長的經濟體中。以印度500億美元的製藥產業為例，製藥業的蓬勃發展也促進了藻類來源的DHA在滿足不斷變化的醫療需求方面的應用。

消費者對DHA益處的認知不斷提高，也加速了其普及。 DHA的許多好處，例如促進大腦健康、心血管功能和整體健康，以及對某些特定疾病的益處，例如預防早產、自閉症、注意力缺陷過動症（ADHD）、憂鬱症和抗生素引起的腸道炎症，都推動了市場對DHA補充劑的需求。藻油調節腸道菌叢和代謝的能力增強了其治療價值。監管政策的發展也支持這一趨勢，證實了藻類來源的DHA在嬰幼兒營養等敏感應用領域的有效性。

DHA市場按應用領域細分：在製藥領域，它被廣泛用於嬰兒奶粉、孕期補充劑以及治療阿茲海默症、過動症和心血管疾病的藥物中。在食品飲料領域，它被用於強化牛奶、優格、雞蛋和麵包等產品。其他應用包括作為飼料添加劑用於動物營養、用於水產養殖以促進生物健康以及用於化妝品以達到護膚功效。

受消費者日益增強的永續性和環境保護意識的推動，歐洲市場預計將佔據相當大的佔有率。消費者對Omega-3脂肪酸有益於大腦和心臟健康的認知不斷提高，加上成熟的營養保健品和製藥基礎設施，為強大的分銷網路提供了支撐。零售藥品支出的成長也進一步推動了該地區對藻類來源DHA產品的需求。

關鍵挑戰在於價格競爭。由於藻類來源的DHA需要受控的培養環境和特殊的萃取技術，其生產成本較高，這可能會限制其與魚油替代品相比的供應量。然而，不斷成長的需求和技術的持續進步有望降低成本，使永續的植物來源產品更具經濟可行性。

就市場趨勢而言，Aker BioMarin 的 Lisobet™ 於 2023 年 8 月在美國獲得新食品成分 (NDI)核准。該成分是一種有益大腦健康的成分，提供源自磷蝦的磷脂結合 EPA/DHA，核准擴大了面向普通成年人群的銷售，從而推出了旨在支持認知功能的補充劑。

公司知名產品包括Corbion的AlgaPrime™ DHA，這是一種用於動物飼料的植物性Omega-3來源，由在封閉池塘中培養的專有單細胞藻類製成。它採用高DHA含量的包封油，呈現流動性良好的粉末狀，優先考慮飼料配方的永續性和可靠性。

Jedwards International 提供含有 40% DHA 的蒸餾藻油，這是一種植物來源補充劑，滿足了人們對非海洋來源的Omega-3的需求，omega-3 是人類健康和福祉所必需的。

ProCaps Laboratories 的 Algal DHA 250 是一種高濃度、非基因改造藻油配方，作為一種永續的植物來源DHA 補充劑而開發，旨在滿足消費者對環境友好型Omega-3產品的需求。

藻類來源的DHA領域正處於多種趨勢的交匯點，包括日益增強的健康意識、永續性需求以及監管支持。作為一種用途廣泛且環境友善的成分，DHA可應用於包括藥品、營養補充劑和食品強化劑在內的許多領域，隨著生產效率的提高和人們對其多方面益處的認知不斷加深，該產品具有持續成長的潛力，尤其是在歐洲。

本報告的主要優勢：

• 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
• 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
• 可操作的建議：利用這些見解，在快速變化的環境中做出策略決策，並發現新的商機和收入來源。
• 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

企業如何使用我們的報告？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍：

• 2021年至2025年的歷史數據和2026年至2031年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區（包括國家）分類的收入和預測評估
• 公司概況（策略、產品、財務資訊）及主要發展動態。

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

5. 藻類來源的二十二碳六烯酸 (DHA) 市場按應用領域分類

• 介紹
• 製藥
• 飲食
• 其他

6. 藻類來源的二十二碳六烯酸 (DHA) 市場按形式分類

• 介紹
• 油
• 粉末
• 軟膠囊

7. 藻類來源的二十二碳六烯酸 (DHA) 市場按應用領域分類

• 介紹
• 對於個人
• 工業的

8. 各地區藻類來源的二十二碳六烯酸 (DHA) 市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第10章：公司簡介

• Corbion
• AlgiSys BioSciences Inc.
• Bioriginal Food & Science Corp
• ALGANEX GmbH
• childlifenutrition.com
• Apeiron Elementals
• LUS Health Ingredients BV
• Life's Code
• ProCaps Laboratories, LLC
• Jedwards International, Inc.

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

Algal Docosahexaenoic Acid (DHA) Market, sustaining a 6.9% CAGR, is anticipated to rise from USD 1.438 billion in 2025 to USD 2.146 billion in 2031.

Algal docosahexaenoic acid (DHA), an essential omega-3 fatty acid critical for brain development and function, has emerged as a sustainable, vegetarian alternative to traditional fish-derived sources. Produced from microalgae, algal DHA addresses overfishing concerns and environmental impacts associated with marine harvesting, while catering to vegan and vegetarian consumers who require external DHA intake, as the human body synthesizes limited quantities endogenously. The broader DHA market encompasses applications in pharmaceuticals, food and beverage, and diverse other sectors, with forms including oils, powders, and soft gels, serving both individual consumers and industrial end-users.

Market growth is significantly driven by expansion in the nutraceutical and pharmaceutical industries. Rising demand for high-quality dietary supplements positions algal DHA as a key ingredient, particularly in rapidly developing economies across Asia Pacific and Africa. The pharmaceutical sector's evolution, exemplified by India's industry reaching a $50 billion valuation, underscores increasing incorporation of algal DHA to meet evolving healthcare demands.

Heightened consumer awareness of DHA's benefits further accelerates adoption. Recognition of its roles in supporting brain health, cardiovascular function, overall wellness, and specific conditions-such as preterm birth prevention, autism, ADHD, depression, and antibiotic-induced intestinal inflammation-has spurred supplement demand. Algal oil's efficacy in modulating gut microbiome and metabolome profiles enhances its therapeutic appeal. Regulatory milestones reinforce this trend, providing validation for algal DHA in sensitive applications like infant nutrition.

The DHA market exhibits segmentation by application: in pharmaceuticals, it features prominently in infant formulas, pregnancy supplements, and treatments for Alzheimer's, ADHD, and cardiovascular conditions; in food and beverage, it fortifies products including milk, yogurt, eggs, and bread. Additional uses span animal nutrition via feed incorporation, aquaculture for healthier organisms, and cosmetics for skincare benefits.

Europe is projected to command a substantial market share, fueled by consumer priorities on sustainability and environmental stewardship. Growing acknowledgment of omega-3 advantages for brain and heart health, combined with a mature nutraceutical and pharmaceutical infrastructure, supports robust distribution channels. Elevated retail pharmaceutical spending further bolsters regional demand for algal DHA products.

A primary challenge involves competitive pricing dynamics. Algal DHA production entails higher costs due to controlled cultivation environments and specialized extraction techniques, potentially limiting accessibility compared to fish oil alternatives. However, escalating demand and ongoing technological improvements are expected to drive cost reductions, enhancing economic viability for sustainable, plant-based options.

In market developments, Aker BioMarine's LYSOVETA(TM), a brain health ingredient delivering LPC-bound EPA/DHA from krill, secured new dietary ingredient (NDI) status in the United States in August 2023. This approval expands marketing authorization to the general adult population, introducing a targeted supplement for cognitive support.

Notable company offerings include Corbion's AlgaPrime(TM) DHA, a vegetarian omega-3 source for animal feed. Derived from a single-cell algal strain grown in enclosed ponds using proprietary methods, it features encapsulated high-DHA oil in a free-flowing powder format, prioritizing sustainability and reliability in feed formulations.

Jedwards International, Inc. provides Algae Oil with 40% DHA concentration, refined through distillation and incorporating tocopherol. This plant-based supplement addresses demand for non-marine omega-3 sources essential for human health and wellness.

ProCaps Laboratories, LLC's Algal DHA 250 delivers a highly concentrated, non-GMO algal oil formulation, developed as a sustainable plant-based DHA supplement responsive to consumer preferences for eco-friendly omega-3 options.

The algal DHA sector is advancing amid converging trends of health consciousness, sustainability imperatives, and regulatory support. Its positioning as a versatile, environmentally responsible ingredient across pharmaceuticals, nutraceuticals, food fortification, and beyond underscores potential for continued expansion, particularly in Europe, as production efficiencies improve and awareness of its multifaceted benefits proliferates.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Algal Docosahexaenoic Acid (DHA) Market Segmentation

• By Application
• Pharmaceuticals
• Food and Beverage
• Others
• By Form
• Oil
• Powder
• Softgel
• By End User
• Individuals
• Industrial
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Pharmaceuticals
• 5.3. Food And Beverage
• 5.4. Others

6. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY FORM

• 6.1. Introduction
• 6.2. Oil
• 6.3. Powder
• 6.4. Softgel

7. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Individuals
• 7.3. Industrial

8. ALGAL DOCOSAHEXAENOIC ACID (DHA) MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Corbion
• 10.2. AlgiSys BioSciences Inc.
• 10.3. Bioriginal Food & Science Corp
• 10.4. ALGANEX GmbH
• 10.5. childlifenutrition.com
• 10.6. Apeiron Elementals
• 10.7. LUS Health Ingredients BV
• 10.8. Life's Code
• 10.9. ProCaps Laboratories, LLC
• 10.10. Jedwards International, Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations